Literature DB >> 26806376

Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria.

Ulrike Klotz1, Dirk Schmidt1, Birgit Willinger2, Eike Steinmann3, Jan Buer1, Peter-Michael Rath1, Joerg Steinmann1.   

Abstract

Echinocandin resistance in Candida glabrata is emerging and is associated with the presence of FKS mutations. In this study, we analysed the antifungal susceptibility, presence of FKS mutations and clonality of C. glabrata blood culture isolates from two hospitals in Germany and Austria. Susceptibility testing of 64 C. glabrata bloodstream isolates from two university hospitals was performed with broth microdilution method according to EUCAST. In addition, all isolates were screened for FKS mutations. Molecular fingerprinting was performed by microsatellite PCR with three separate primer pairs and semiautomated repetitive sequenced-based PCR (rep-PCR). One C. glabrata isolate from Germany (1.5%) was echinocandin resistant, with a corresponding mutation in FKS2 gene hot spot 1. The discriminatory power of microsatellite PCR was higher than that of rep-PCR (Simpson Index of 0.94 vs. 0.88); microsatellite PCR created 31 separate genotypes, whereas rep-PCR created 17. Predominant genotypes or clusters of isolates from Germany and Austria were present, with no epidemiological evidence of nosocomial transmissions. Although we found a low incidence of echinocandin resistance in C. glabrata in our settings, further surveillance projects in central Europe are warranted for monitoring future epidemiological trends. The genetic population structure of C. glabrata demonstrates overrepresented geographical clusters.
© 2016 Blackwell Verlag GmbH.

Entities:  

Keywords:  Candida glabrata; caspofungin resistance; echinocandin; genotyping; microsatellite PCR; rep-PCR

Mesh:

Substances:

Year:  2016        PMID: 26806376     DOI: 10.1111/myc.12472

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  19 in total

1.  MSH2 Gene Point Mutations Are Not Antifungal Resistance Markers in Candida glabrata.

Authors:  Pilar Escribano; Jesús Guinea; María Ángeles Bordallo-Cardona; Caroline Agnelli; Ana Gómez-Nuñez; Carlos Sánchez-Carrillo; Emilio Bouza; Patricia Muñoz
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 2.  Antifungal Susceptibility Testing: Current Approaches.

Authors:  Elizabeth L Berkow; Shawn R Lockhart; Luis Ostrosky-Zeichner
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

3.  Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan.

Authors:  Hazim O Khalifa; Teppei Arai; Hidetaka Majima; Akira Watanabe; Katsuhiko Kamei
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

4.  Clonal Spread of Candida glabrata Bloodstream Isolates and Fluconazole Resistance Affected by Prolonged Exposure: a 12-Year Single-Center Study in Belgium.

Authors:  Berdieke Goemaere; Katrien Lagrou; Isabel Spriet; Marijke Hendrickx; Pierre Becker
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

5.  Profiling of PDR1 and MSH2 in Candida glabrata Bloodstream Isolates from a Multicenter Study in China.

Authors:  Xin Hou; Meng Xiao; He Wang; Shu-Ying Yu; Ge Zhang; Yanan Zhao; Ying-Chun Xu
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

6.  Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway.

Authors:  Ashutosh Singh; Kelley R Healey; Priyanka Yadav; Gargi Upadhyaya; Neelam Sachdeva; Smita Sarma; Anil Kumar; Bansidhar Tarai; David S Perlin; Anuradha Chowdhary
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

7.  Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance.

Authors:  Sarah Dellière; Kelley Healey; Maud Gits-Muselli; Bastien Carrara; Alessandro Barbaro; Nicolas Guigue; Christophe Lecefel; Sophie Touratier; Marie Desnos-Ollivier; David S Perlin; Stéphane Bretagne; Alexandre Alanio
Journal:  Front Microbiol       Date:  2016-12-23       Impact factor: 5.640

8.  Low Level of Antifungal Resistance in Iranian Isolates of Candida glabrata Recovered from Blood Samples in a Multicenter Study from 2015 to 2018 and Potential Prognostic Values of Genotyping and Sequencing of PDR1.

Authors:  Amir Arastehfar; Farnaz Daneshnia; Kamiar Zomorodian; Mohammad Javad Najafzadeh; Sadegh Khodavaisy; Hossein Zarrinfar; Ferry Hagen; Zahra Zare Shahrabadi; Michaela Lackner; Hossein Mirhendi; Mohammadreza Salehi; Maryam Roudbary; Weihua Pan; Markus Kostrzewa; Teun Boekhout
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

9.  Genetic diversity assessed using PFGE, MLP and MLST in Candida spp. candidemia isolates obtained from a Brazilian hospital.

Authors:  Heliara Maria Spina Canela; Bárbara Cardoso; Miliane Rodrigues Frazão; Juliana Pfrimer Falcão; Lucia Helena Vitali; Roberto Martinez; Márcia Eliana da Silva Ferreira
Journal:  Braz J Microbiol       Date:  2021-02-20       Impact factor: 2.476

Review 10.  Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies.

Authors:  Maria N Gamaletsou; Thomas J Walsh; Nikolaos V Sipsas
Journal:  Turk J Haematol       Date:  2018-02-02       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.